An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer

被引:43
|
作者
Shui, Ruohong [1 ,2 ]
Yu, Baohua [1 ,2 ]
Bi, Rui [1 ,2 ]
Yang, Fei [1 ,2 ]
Yang, Wentao [1 ,2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 05期
关键词
LABELING INDEX; INTERNATIONAL KI67; PROLIFERATION; KI-67; METAANALYSIS; PROGNOSIS; ACCURACY; MARKER;
D O I
10.1371/journal.pone.0125131
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast cancer. However, standardised methodologies for measurement are lacking which has limited its application in clinical practice. In this study, we evaluated the interobserver concordance of visual assessment of Ki67 LI in breast cancer. Methods Ki67-immunostained slides of 160 cases of primary invasive breast cancer were visual assessed by five breast pathologists with two different methods to choose the scoring fields: (1) hot-spot score, (2) average score. Proportions of positive invasive tumor cells at 10 % intervals were scored. The intra-class correlation coefficient (ICC) was used to assess the interobserver reproducibility. Results (1) A perfect concordance of Ki67 LI was demonstrated according to both score methods (P<0.0001). Average score method (ICC, 0.904) demonstrated a better correlation than hotspot score method (ICC, 0.894). (2) By respective means according to two score methods, all cases were classified into three groups (<= 10%, 11%-30% and >30% Ki-67 LI). The concordance was relatively low in intermediate Ki67 LI group compared with low and high Ki67 LI groups. (3) All cases were classified into three groups by paired-difference (d) between means of hot-spot score and average score (d<5, 5 <= d<10, d >= 10). The consistency was observed to decrease with increasing paired-difference according to both methods. Conclusions Visual assessment of Ki67 LI at 10% intervals is a candidate for a standard method in breast cancer clinical practice. Average score and hot-spot score of visual assessment both demonstrated a perfect concordance, and an overall average assessment across the whole section including hot spots may be a better method. Interobserver concordance of intermediate Ki67 LI in which most cutoffs are located for making clinical decisions was relatively low.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Implementation of Digital Image Analysis in Assessment of Ki67 Index in Breast Cancer
    Vanderschelden, Rachel K.
    Jerome, Jacob A.
    Gonzalez, Daniel
    Seigh, Lindsey
    Carter, Gloria J.
    Clark, Beth Z.
    Elishaev, Esther
    Louis Fine, Jeffrey
    Harinath, Lakshmi
    Jones, Mirka W.
    Villatoro, Tatiana M.
    Soong, Thing Rinda
    Yu, Jing
    Zhao, Chengquan
    Hartman, Doug
    Bhargava, Rohit
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2024, 32 (01) : 17 - 23
  • [22] Ki67 and breast cancer mortality in women with invasive breast cancer
    Probert, Jake
    Dodwell, David
    Broggio, John
    Charman, Jackie
    Dowsett, Mitch
    Kerr, Amanda
    McGale, Paul
    Taylor, Carolyn
    Darby, Sarah C.
    Mannu, Gurdeep S.
    JNCI CANCER SPECTRUM, 2023, 7 (05)
  • [23] Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer
    Stalhammar, Gustav
    Robertson, Stephanie
    Wedlund, Lena
    Lippert, Michael
    Rantalainen, Mattias
    Bergh, Jonas
    Hartman, Johan
    HISTOPATHOLOGY, 2018, 72 (06) : 974 - 989
  • [24] Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
    Muftah, Abir A.
    Aleskandarany, Mohammed A.
    Al-kaabi, Methaq M.
    Sonbul, Sultan N.
    Diez-Rodriguez, Maria
    Nolan, Chris C.
    Caldas, Carlos
    Ellis, Ian O.
    Rakha, Emad A.
    Green, Andrew R.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (02) : 341 - 348
  • [25] Interlaboratory variability of Ki67 staining in breast cancer
    Focke, Cornelia M.
    Buerger, Horst
    van Diest, Paul J.
    Finsterbusch, Kai
    Glaeser, Doreen
    Korsching, Eberhard
    Decker, Thomas
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 219 - 227
  • [26] An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma
    Papathomas, Thomas G.
    Pucci, Eugenio
    Giordano, Thomas J.
    Lu, Hao
    Duregon, Eleonora
    Volante, Marco
    Papotti, Mauro
    Lloyd, Ricardo V.
    Tischler, Arthur S.
    van Nederveen, Francien H.
    Nose, Vania
    Erickson, Lori
    Mete, Ozgur
    Asa, Sylvia L.
    Turchini, John
    Gill, Anthony J.
    Matias-Guiu, Xavier
    Skordilis, Kassiani
    Stephenson, Timothy J.
    Tissier, Frederique
    Feelders, Richard A.
    Smid, Marcel
    Nigg, Alex
    Korpershoek, Esther
    van der Spek, Peter J.
    Dinjens, Winand N. M.
    Stubbs, Andrew P.
    de Krijger, Ronald R.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (04) : 569 - 576
  • [27] Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility
    Hida, Akira I.
    Bando, Kenji
    Sugita, Atsuro
    Maeda, Toshiharu
    Ueda, Norifumi
    Matsukage, Shoichi
    Nakanishi, Mamoru
    Kito, Katsumi
    Miyazaki, Tatsuhiko
    Ohtsuki, Yuji
    Oshiro, Yumi
    Inoue, Hiromichi
    Kawaguchi, Hidetoshi
    Yamashita, Natsumi
    Aogi, Kenjiro
    Moriya, Takuya
    JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (05) : 356 - 361
  • [28] Prognostic Significance of the Ki67 Scoring Categories in Breast Cancer Subgroups
    Niikura, Naoki
    Masuda, Shinobu
    Kumaki, Nobue
    Tang Xiaoyan
    Terada, Mizuho
    Terao, Mayako
    Iwamoto, Takayuki
    Oshitanai, Risa
    Morioka, Toru
    Tuda, Banri
    Okamura, Takuho
    Saito, Yuki
    Suzuki, Yasuhiro
    Tokuda, Yutaka
    CLINICAL BREAST CANCER, 2014, 14 (05) : 323 - 329
  • [29] Expression, assessment and significance of Ki67 expression in breast cancer: an update
    Lashen, Ayat Gamal
    Toss, Michael S.
    Ghannam, Suzan Fathy
    Makhlouf, Shorouk
    Green, Andrew
    Mongan, Nigel P.
    Rakha, Emad
    JOURNAL OF CLINICAL PATHOLOGY, 2023, 76 (06) : 357 - 364
  • [30] An Intra- and Interobserver Reproducibility Analysis of the Ki-67 Proliferation Marker Assessment on Core Biopsies of Breast Cancer Patients and Its Potential Clinical Implications
    Voeroes, Andras
    Csoergo, Erika
    Nyari, Tibor
    Cserni, Gabor
    PATHOBIOLOGY, 2013, 80 (03) : 111 - 118